Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs VEU✓SelectedUSD · VEUGSK vs VEU performance historyLatest closeAs of-0.13%11/20
Stock and ETF performance explorer

GSK vs VEU

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+52.7%
VEU return
+49.4%
Excess return
+3.3%
Maximum drawdown
-28.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioVEUExcessAlpha
1D-0.1%-3.3%+3.2%+1.3%
7D-5.3%-8.8%+3.5%-1.5%
30D-3.7%-10.2%+6.5%+0.9%
3M-7.3%-13.0%+5.7%-1.6%
6M-4.2%-9.5%+5.3%-0.7%
YTD+0.9%+1.2%-0.3%-2.0%
1Y+7.3%+7.7%-0.4%+0.7%
3Y+52.7%+48.6%+4.2%+19.5%
All+52.7%+49.4%+3.3%+19.5%

Cumulative growth

Daily Returns

Daily percentage return beside VEU.

Daily Out/Under-Performance

Portfolio return minus VEU return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × VEU return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded VEU wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling